Patents by Inventor Richard I. Schwarz

Richard I. Schwarz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10428093
    Abstract: Herein is described a cell density signaling protein and its tissue-specific lipid cofactor. Constructs, compositions and methods for isolation, purification and use of the protein and the tissue-specific lipid cofactor are described.
    Type: Grant
    Filed: April 25, 2016
    Date of Patent: October 1, 2019
    Inventor: Richard I. Schwarz
  • Publication number: 20160251386
    Abstract: Herein is described a cell density signaling protein and its tissue-specific lipid cofactor. Constructs, compositions and methods for isolation, purification and use of the protein and the tissue-specific lipid cofactor are described.
    Type: Application
    Filed: April 25, 2016
    Publication date: September 1, 2016
    Inventor: Richard I. Schwarz
  • Patent number: 6433136
    Abstract: Identification, isolation and partial sequencing of a cell density protein produced by fibroblastic cells. The cell density signal protein comprising a 14 amino acid peptide or a fragment, variant, mutant or analog thereof, the deduced cDNA sequence from the 14 amino acid peptide, a recombinant protein, protein and peptide-specific antibodies, and the use of the peptide and peptide-specific antibodies as therapeutic agents for regulation of cell differentiation and proliferation. A method for treatment and repair of connective tissue and tendon injuries, collagen deficiency, and connective tissue defects.
    Type: Grant
    Filed: December 17, 1998
    Date of Patent: August 13, 2002
    Assignee: The Regents of the University of California
    Inventor: Richard I. Schwarz
  • Patent number: 6245899
    Abstract: Disclosed herein is a novel proteinaceous cell density signal molecule (CDS), which is secreted by fibroblastic cells in culture, preferably tendon cells, and which provides a means by which the cells self-regulate their proliferation and the expression of differentiated function. CDS, and the antibodies which recognize them, are important for the development of diagnostics and treatments for injuries and diseases involving connective tissues, particularly tendon. Also disclosed are methods of production and use.
    Type: Grant
    Filed: April 17, 1998
    Date of Patent: June 12, 2001
    Assignee: The Regents of the University of California
    Inventor: Richard I. Schwarz
  • Patent number: 5741895
    Abstract: Disclosed herein is a novel proteinaceous cell density signal molecule (CDS) between 25 and 35 kD, which is secreted by fibroblastic primary avian tendon cells in culture, and causes the cells to self-regulate their proliferation and the expression of differentiated function. It effects an increase of procollagen production in avian tendon cell cultures of ten fold while proliferation rates are decreased. CDS, and the antibodies which recognize them, are important for the development of diagnostics and treatments for injuries and diseases involving connective tissues, particularly tendon. Also disclosed are methods of production and use.
    Type: Grant
    Filed: May 19, 1995
    Date of Patent: April 21, 1998
    Assignee: The Regents of the University of California
    Inventor: Richard I. Schwarz